Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 4
2007 4
2010 1
2011 1
2012 1
2015 1
2016 1
2017 4
2018 2
2019 3
2020 4
2021 1
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Design and Synthesis of Orexin 1 Receptor-Selective Agonists.
Iio K, Hashimoto K, Nagumo Y, Amezawa M, Hasegawa T, Yamamoto N, Kutsumura N, Takeuchi K, Ishikawa Y, Yamamoto H, Tokuda A, Sato T, Uchida Y, Inoue A, Tanimura R, Yanagisawa M, Nagase H, Saitoh T. Iio K, et al. Among authors: nagumo y. J Med Chem. 2023 Apr 27;66(8):5453-5464. doi: 10.1021/acs.jmedchem.2c01773. Epub 2023 Apr 12. J Med Chem. 2023. PMID: 37043436
Unexpected Rearrangement Reactions of the 14-Aminonaltrexone Skeleton.
Maeda K, Ohrui S, Tokuda A, Nagumo Y, Yamamoto N, Tanimura R, Saitoh T, Kutsumura N, Nagase H. Maeda K, et al. Among authors: nagumo y. Org Lett. 2023 May 19;25(19):3407-3411. doi: 10.1021/acs.orglett.3c00956. Epub 2023 May 8. Org Lett. 2023. PMID: 37154730
Favorskii-Type Rearrangement of the 4,5-Epoxymorphinan Skeleton.
Kutsumura N, Koyama Y, Suzuki Y, Tominaga KI, Yamamoto N, Saitoh T, Nagumo Y, Nagase H. Kutsumura N, et al. Among authors: nagumo y. Org Lett. 2018 Mar 16;20(6):1559-1562. doi: 10.1021/acs.orglett.8b00288. Epub 2018 Mar 7. Org Lett. 2018. PMID: 29513016
Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives.
Katoh K, Kutsumura N, Yamamoto N, Nagumo Y, Saitoh T, Ishikawa Y, Irukayama-Tomobe Y, Tanimura R, Yanagisawa M, Nagase H. Katoh K, et al. Among authors: nagumo y. Bioorg Med Chem Lett. 2022 Mar 1;59:128550. doi: 10.1016/j.bmcl.2022.128550. Epub 2022 Jan 15. Bioorg Med Chem Lett. 2022. PMID: 35041942
Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library.
Saitoh T, Amezawa M, Horiuchi J, Nagumo Y, Yamamoto N, Kutsumura N, Ohshita R, Tokuda A, Irukayama-Tomobe Y, Ogawa Y, Ishikawa Y, Hasegawa E, Sakurai T, Uchida Y, Sato T, Gouda H, Tanimura R, Yanagisawa M, Nagase H. Saitoh T, et al. Among authors: nagumo y. Eur J Med Chem. 2022 Oct 5;240:114505. doi: 10.1016/j.ejmech.2022.114505. Epub 2022 Jun 13. Eur J Med Chem. 2022. PMID: 35839689
36 results